HAL vs ICCC · P/E 9.3, $19.05B cap vs rev $26.5M
Halliburton Company (HAL) versus ImmuCell Corporation (ICCC) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. ICCC currently screens at market cap $58.9M.
Not investment advice. Open the HAL and ICCC stock pages for the full models.
Not investment advice.